CYCC Chart
- 52-Week Range: $1.28 - $7.30
- Market Capitalization: $13.49M
- Short Percentage: 0%
- Target Price: $20.00
- Shares Outstanding: 9.99M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CYCC released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Cyclacel Pharmaceuticals Reviews 2021 Achievements And Announces Key Business Objectives for 2022GlobeNewsWire | January 6th
- Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 10th
- Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire | August 11th
Company Info
Website: https://www.cyclacel.com
Address: 200 Connell Drive, Berkeley Heights, NJ, United States, 07922
Sector: Healthcare
Industry: Biotechnology
Full time employees: N/A
Address: 200 Connell Drive, Berkeley Heights, NJ, United States, 07922
Sector: Healthcare
Industry: Biotechnology
Full time employees: N/A
$CYCC how much did you make this past week?
$CYCC NOT SELLING.
$CYCC buying!
$CYCC MACD turned bullish
$CYCC is going to have a run next month
$CYCC volume is almost nonexistent
$CYCC Holding Strong since January ??????????